<DOC>
	<DOCNO>NCT00545259</DOCNO>
	<brief_summary>The study evaluate pharmacokinetic profile AEB071 immediate post-transplant period patient undergo first liver transplant .</brief_summary>
	<brief_title>Pharmacokinetic Study AEB071 Patients Following Liver Transplantation</brief_title>
	<detailed_description />
	<criteria>Primary liver transplant recipient . Transplanted liver function acceptable level 24 h posttransplant Patients start tacrolimus therapy within 12 h posttransplant Previous transplantation multiple organ transplantation Acute rejection Nonheart beating donor Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Organ transplant , liver , pharmacokinetics , AEB071 , immunosuppression</keyword>
</DOC>